, an health IT company based in Singapore, today announced that it’s raised $35 million in a series B financing round led by Sequoia Capital’s Sequoia India and MassMutual Ventures, with participation from Singapore government-linked strategic investor EDBI, Chinese online health care platform Jianke, Openspace Ventures, Aviva Ventures, and SGInnovate. It brings the company’s total raised to over $40 million, according to Crunchbase, and will fuel its ongoing commercialization efforts in the U.S. and Asia and the growth of its data science, clinical and regulatory, and sales and operations teams.

By the end of 2019, the Biofourmis aims to have a workforce north of 100 employees in the U.S. and Singapore, said founder and CEO Kuldeep Singh Rajput, and the firm plans to move its

Read More At Article Source | Article Attribution